newsfilter
← Latest News
Business Wire·

Sierra Oncology to Participate in the Oppenheimer 32nd Annual Healthcare Conference

Sierra Oncology, Inc. (NASDAQ:SRRA), a late-stage biopharmaceutical company dedicated to delivering targeted therapies for rare cancers, today announced the company will participate in the 32nd Annual Oppenheimer Healthcare Conference being held virtual